Hepion Pharmaceuticals Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 1,281 | 1,202 | 4,458 | 8,504 | 5,182 |
| Operating Income | -1,281 | -1,202 | -4,458 | -8,504 | -5,182 |
| Interest Expense | 25 | 818 | 475 | -50 | 4 |
| Other Income | -4,801 | 473 | 67 | 4,529 | -637 |
| Pre-tax Income | -6,106 | -1,548 | -4,866 | -3,925 | -5,823 |
| Income Tax | N/A | N/A | N/A | N/A | -2,969 |
| Net Income Continuous | -6,106 | -1,548 | -4,866 | -3,925 | -2,854 |
| Net Income | $-6,106 | $-1,548 | $-4,866 | $-3,925 | $-2,854 |
| EPS Basic Total Ops | -2.15 | -9.22 | -36.00 | -34.00 | -28.13 |
| EPS Basic Continuous Ops | -2.15 | -8.95 | -36.21 | -33.84 | -28.26 |
| EPS Diluted Total Ops | -2.15 | -9.22 | -36.00 | -34.00 | -28.13 |
| EPS Diluted Continuous Ops | -2.15 | -8.95 | -36.21 | -33.84 | -28.26 |
| EPS Diluted Before Non-Recurring Items | -2.15 | N/A | -36.00 | -34.00 | -28.00 |
| EBITDA(a) | $-1,281 | $-408 | $-3,984 | $-8,504 | $-5,152 |